Drug intelligence / Profile preview

GastroBalance Reflu

Development stage
Unknown
Lead developer
Kwizda Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

GastroBalance Reflu is an over-the-counter medical device developed and marketed by Kwizda Pharma for the treatment of gastroesophageal reflux disease (GERD), heartburn, and associated symptoms such as acid reflux, dry cough, and dysphagia. Unlike traditional pharmacological treatments, it operates through a physical, four-fold mechanism of action. The product contains galactomannans from fenugreek seeds, which create a mechanical bio-barrier on top of the stomach contents to prevent reflux; wild mallow extract (*Malva sylvestris*) and sodium hyaluronate, which form a protective film on the esophageal mucosa and support the regeneration of irritated tissue; and calcium carbonate and sodium bicarbonate, which neutralize gastric acid. It is available in oral formulations, including direct-stick sachets and chewable tablets, and is suitable for vegetarians and vegans.

Brand names
GastroBalance Reflu
Other names
GastroBalance Reflu-Kwizda Pharma

Beyond the preview

Go deeper on GastroBalance Reflu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GastroBalance Reflu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call